Fig. 6.

Cell viability of human neurons co-treated with EtOAc and < 10 kDa peptidic fraction from kefir and synthetic Aβ. Group that received Aβ significantly decreased the cell viability compared to the untreated group (p  = 0.0101). Only the treatments of synthetic peptide Aβ pre-incubated with EtOAc fraction at the concentration of 0.25 and 0.1 mg/mL showed an increased viability compared to the Aβ group (p  = 0.0044 and p  = 0.0007 respectively). The data are shown as individual values, the mean ± S.E.M. (unpaired t test).